• Of Mice and Men: Edison Liu Leaves Singapore to Head Jackson Laboratory

    Bio-IT World | Edison Liu, arguably the most prominent medical researcher in Singapore and the two-term president of the Human Genome Organization (HUGO), is returning to the United States after ten years to become the new president and CEO of The Jackson Laboratory in Bar Harbor, Maine.

    Aug 26, 2011

  • UK Launches Cancer Genomics Project

    Nature News | The UK will launch a personalized medicine pilot project next month. The project will be led by Cancer Research UK and the Stratified Medicine Proamme and will screen 9,000 cancer patients.

    Aug 26, 2011

  • Samsung Launches Genome Analysis Service, Offers Free Genome

    Bio-IT World | Samsung SDS is launching beta testing of its new next generation sequencing data analysis service beginning September 1. The service will be in beta testing mode from September to November and will be offering free genome analysis (one genome per researcher) during the testing phase.

    Aug 23, 2011

  • NHGRI Funds Electronic Medical Record Genomics Network

    Bio-IT World | Grants worth $25 millions over the next four years from the National Human Genome Research Institute (NHGRI) will support researchers that are part of the Electronic Medical Records and Genomics (eMERGE) network.The grants will fund research to demonstrate that patients' genomic information linked to disease characteristics and symptoms in their electronic medical records can be used to improve their care.    

     

    Aug 22, 2011

  • Big-Bucks Biology's Broken Business Model

    Bio-IT World | The Skeptical Outsider | "Tell me how someone is compensated and I’ll tell you how they’ll behave,” goes the old adage. If non-monetary rewards are considered alongside financial remuneration this pretty much describes why federally funded research in the life sciences is producing less and less bang for more and more bucks. And why the scientific literature is at risk of becoming polluted with overreaching claims, obfuscated shortcomings, and non-reproducible results. 

     

    Aug 22, 2011

  • Mary Jane's First Genome

    Boston Herald | Kevin McKernan, chief developer of the SOLiD platform, has a new venture and has been spending quite a lot of time with the Cannabis plant. Medicinal Genomics has announced the full genome sequencing of Cannabis.

    Aug 18, 2011

  • Stanford Team Reports Advance in Computational Drug Repositioning

    Wall Street Journal | In a spot of "educated fishing," Atul Butte and colleagues at Stanford University report an innovative way to identify and reposition drugs against diseases they weren't originally designed to combat. The stories of two such repurposed drugs, targeting inflammatory bowel disease and lung cancer, are described in a pair of new papers in the journal Science Translational Medicine.

    Aug 17, 2011

  • Cancer and the Genome: The Bigger Picture

    New York Times | New theories about cancer suggest pseudogenes in the noncoding regions of DNA and microbial gene exchange may be behind the development of some cancers. 

    Aug 17, 2011

  • Evolution of the Textbook

    HHMI Bulletin | Publishers are beginning to go digital with biology textbooks, pushing boundaries to give students a more personalized, interactive experience.

    Aug 16, 2011

  • DREAM6 Breaks New Ground

    Bio-IT World | Roughly five years ago the organizers of DREAM—Dialogue for Reverse Engineering Assessment and Methods—set out to find the best algorithms for inferring biological networks from blinded data sets. It turns out there's no such critter as the perfect algorthm.  

    Aug 15, 2011

  • Halcyon Molecular: Anatomy of a NGS Start-Up

    The Independent | William and Michael Andregg, co-founders of Silicon Valley next-gen sequencing start-up Halcyon Molecular, have given their most extensive interview to date on the motivation and circumstances that led to the launch of this ambitious company in 2008, funded in large part by the 'PayPal mafia.' 

    Aug 15, 2011

  • Back to Berlin for PacBio's Jonas Korlach

    San Jose Mercury News | The co-founder of Pacific Biosciences, Jonas Korlach, is preparing to return to Berlin for the official unveiling of the first PacBio instrument in his native land. In 1989, a 16-year-old Korlach walked through the Brandenburg Gate, just a few miles from his home in East Berlin. 

     

    Aug 12, 2011

  • Five Questions for Broad Institute CIO Martin Leach

    Broad Institute | Settling into his new digs at the Broad Institute, CIO Martin Leach answers five questions about IT at the Broad, his journey to the institute, and lessons that can be learned from the world of video gaming.

    Aug 12, 2011

  • Data for Doctors: Big Data Meets a Big Business

    GigaOM | Ted Corbett, director of knowledge management at Seattle Children’s Hospital, is using software from a company called Tableau to draw smart inferences from the 10 terabytes of data locked up in his servers and warehousing appliances.

    Aug 9, 2011

  • Turning Blood into Gold: The Wellness Chip

    Bio-IT World | COVER STORY: Fourteen years after conceiving a tool to discover and measure protein biomarkers, Larry Gold and his colleagues at SomaLogic are poised to see their first diagnostic—a lung cancer blood test--reach the marketplace.

    Aug 5, 2011

  • UK Study Identifies Ovarian Cancer Risk Gene

    The Independent | A new study funded by Cancer Research UK has identified a genetic glitch in a known DNA repair gene that increases a woman's risk of ovarian cancer six-fold. One in every 11 women who carry a mutation in the RAD51D gene is likely to develop ovarian cancer in her lifetime. 

    Aug 8, 2011

  • Genome Analytics for All

    Bio-IT World | Pauline Ng is planning open source, open access analytics for the genomes to come.

    Aug 5, 2011

  • Ion Torrent Reports 265 Base Pair Reads

    Bio-IT World | Late Wednesday, Life Technologies released an application note and supporting data for the Ion Torrent Personal Genomics Machine reporting reads up to 265 base pairs in length using E. coli data.

    Aug 5, 2011

  • CROs Doing More Research, Discovery

    San Diego Union Tribune | CRO's portion of the drug discovery market is expanding rapidly. In 2010 about 21 percent of R&D spending worldwide went to CROs 

    Aug 3, 2011

  • Time for Pharma to Face Social Media Fears?

    Bio-IT World | Guest Commentary | As tools like Facebook and Twitter become a permanent reality of human interaction, savvy businesses are standing up and taking notice. Yet the pharmaceutical industry remains apprehensive about jumping on the social media bandwagon.  

     

    Aug 1, 2011